NFKB1 and metabolic syndrome: Similarly, the co-administration of resveratrol and omega-3 fatty acids has been shown to improve insulin sensitivity and decrease systemic inflammation in metabolic syndrome by modulating key signaling pathways like NF-κB and MAPK [134,135].